Generation of complement C9 conditional knockout mice and anti-C9 mAbs

补体 C9 条件敲除小鼠和抗 C9 mAb 的生成

基本信息

  • 批准号:
    7706326
  • 负责人:
  • 金额:
    $ 7.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-05 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Complement is important part of the innate immune system and is arguably best known for its ability to lyse bacteria, enveloped viruses and eukaryotic cells through a macro- molecular structure known as the membrane attack complex (MAC). The MAC is composed of several complement proteins (C5b, C6, C7, C8 and C9), but C9 is the critical protein required for the pore-forming structure of the MAC. Because the complement system discriminates poorly between self and non-self under inflammatory conditions, inappropriate activation of complement and subsequent MAC-mediated destruction of self-tissues is a common feature of autoimmune disease. The evidence linking C9 to cell death in this setting is frequently circumstantial, based largely on immunohistochemical staining for C9 in postmortem tissue samples. However in some disease settings, such as demyelinating disease, there are clear discrepancies between the need for C9 and the MAC as important components of the pathogenic mechanism. This raises questions regarding how critical C9 is in demyelinating disease and in other autoimmune diseases where complement-mediated mechanisms are considered central to disease pathology. In addition, there are many unanswered questions regarding C9 biology. For example, does C9 contribute to normal development? What are the regulatory mechanisms for C9 gene expression? What are the C9-mediated signaling events generated on interaction with prokaryotic and eukaryotic membranes? Surprisingly, there are no murine-specific tools to address these questions. We propose to generate C9-specific monoclonal and polyclonal antibodies and conditional C9-deficient mice to provide much needed tools to directly assess of the role of C9 in autoimmune and inflammatory diseases. PUBLIC HEALTH RELEVANCE: The role of the complement component C9 in autoimmune and infectious disease remains poorly explored due to the lack of appropriate reagents. Studies in this application are designed to generate C9 conditional knockout mice and anti-C9 monoclonal antibodies.
描述(由申请人提供):补体是先天免疫系统的重要组成部分,并且可以说最为人所知的是其通过称为膜攻击复合物(MAC)的大分子结构裂解细菌、包膜病毒和真核细胞的能力。MAC由几种补体蛋白(C5 b、C6、C7、C8和C9)组成,但C9是MAC的成孔结构所需的关键蛋白。由于补体系统在炎症条件下对自身和非自身的区分较差,因此补体的不适当激活和随后的MAC介导的自身组织破坏是自身免疫性疾病的常见特征。在这种情况下,将C9与细胞死亡联系起来的证据通常是间接的,主要基于死后组织样本中C9的免疫组织化学染色。然而,在某些疾病环境中,例如脱髓鞘疾病,对C9和MAC作为致病机制的重要组分的需求之间存在明显的差异。这就提出了关于C9在脱髓鞘疾病和其他自身免疫性疾病中的重要性的问题,其中补体介导的机制被认为是疾病病理学的核心。此外,关于C9生物学还有许多未解答的问题。例如,C9是否有助于正常发育?C9基因表达的调控机制是什么?C9与原核和真核细胞膜相互作用产生的信号事件是什么?令人惊讶的是,没有专门针对老鼠的工具来解决这些问题。我们建议产生C9特异性单克隆和多克隆抗体和条件C9缺陷小鼠,以提供急需的工具来直接评估C9在自身免疫性和炎症性疾病中的作用。公共卫生关系:由于缺乏合适的试剂,补体成分C9在自身免疫性疾病和感染性疾病中的作用仍然很少探索。本申请中的研究旨在产生C9条件性敲除小鼠和抗C9单克隆抗体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott R BARNUM其他文献

Scott R BARNUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott R BARNUM', 18)}}的其他基金

The Role of the Terminal Complement Pathway in ALS
终末补体通路在 ALS 中的作用
  • 批准号:
    8511495
  • 财政年份:
    2013
  • 资助金额:
    $ 7.32万
  • 项目类别:
The Role of the Terminal Complement Pathway in ALS
终末补体通路在 ALS 中的作用
  • 批准号:
    8605944
  • 财政年份:
    2013
  • 资助金额:
    $ 7.32万
  • 项目类别:
Complement-based Therapeutics in Demyelinating Disease
脱髓鞘疾病中基于补体的治疗
  • 批准号:
    8117574
  • 财政年份:
    2010
  • 资助金额:
    $ 7.32万
  • 项目类别:
Complement-based Therapeutics in Demyelinating Disease
脱髓鞘疾病中基于补体的治疗
  • 批准号:
    7990776
  • 财政年份:
    2010
  • 资助金额:
    $ 7.32万
  • 项目类别:
RBC age and potentiation of transfusion related pathology in trauma patients
创伤患者的红细胞年龄和输血相关病理的增强
  • 批准号:
    8298545
  • 财政年份:
    2009
  • 资助金额:
    $ 7.32万
  • 项目类别:
RBC age and potentiation of transfusion related pathology in trauma patients
创伤患者的红细胞年龄和输血相关病理的增强
  • 批准号:
    7935322
  • 财政年份:
    2009
  • 资助金额:
    $ 7.32万
  • 项目类别:
Generation of complement C9 conditional knockout mice and anti-C9 mAbs
补体 C9 条件敲除小鼠和抗 C9 mAb 的生成
  • 批准号:
    7860430
  • 财政年份:
    2009
  • 资助金额:
    $ 7.32万
  • 项目类别:
RBC age and potentiation of transfusion related pathology in trauma patients
创伤患者的红细胞年龄和输血相关病理的增强
  • 批准号:
    7760753
  • 财政年份:
    2009
  • 资助金额:
    $ 7.32万
  • 项目类别:
RBC age and potentiation of transfusion related pathology in trauma patients
创伤患者的红细胞年龄和输血相关病理的增强
  • 批准号:
    8106270
  • 财政年份:
    2009
  • 资助金额:
    $ 7.32万
  • 项目类别:
Conference on Central Nervous System Inflammation
中枢神经系统炎症会议
  • 批准号:
    6887144
  • 财政年份:
    2005
  • 资助金额:
    $ 7.32万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 7.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了